Literature DB >> 9420766

The birth of a new radiopharmaceutical. Clinical investigative perspective.

F J Wackers1.   

Abstract

Mesh:

Substances:

Year:  1995        PMID: 9420766     DOI: 10.1016/s1071-3581(05)80012-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  12 in total

1.  Simultaneous measurement of myocardial perfusion and ventricular function during exercise from a single injection of technetium-99m sestamibi in coronary artery disease.

Authors:  R H Jones; S Borges-Neto; J M Potts
Journal:  Am J Cardiol       Date:  1990-10-16       Impact factor: 2.778

2.  Diagnostic value of a new myocardial perfusion agent, teboroxime (SO 30,217), utilizing a rapid planar imaging protocol: preliminary results.

Authors:  R C Hendel; B McSherry; M Karimeddini; J A Leppo
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

3.  A quantitative phantom analysis of artifacts due to hepatic activity in technetium-99m myocardial perfusion SPECT studies.

Authors:  G Germano; T Chua; H Kiat; J S Areeda; D S Berman
Journal:  J Nucl Med       Date:  1994-02       Impact factor: 10.057

4.  Myocardial perfusion imaging with technetium-99m SQ30217: comparison with thallium-201 and coronary anatomy.

Authors:  D W Seldin; L L Johnson; D K Blood; M J Muschel; K F Smith; R M Wall; P J Cannon
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

5.  Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction.

Authors:  R J Gibbons; M S Verani; T Behrenbeck; P A Pellikka; M K O'Connor; J J Mahmarian; J H Chesebro; F J Wackers
Journal:  Circulation       Date:  1989-11       Impact factor: 29.690

6.  Technical aspects of myocardial SPECT imaging with technetium-99m sestamibi.

Authors:  E V Garcia; C D Cooke; K F Van Train; R Folks; J Peifer; E G DePuey; J Maddahi; N Alazraki; J Galt; N Ezquerra
Journal:  Am J Cardiol       Date:  1990-10-16       Impact factor: 2.778

7.  Quantitative analysis of planar technetium-99m-sestamibi myocardial perfusion images using modified background subtraction.

Authors:  K Koster; F J Wackers; J A Mattera; R C Fetterman
Journal:  J Nucl Med       Date:  1990-08       Impact factor: 10.057

8.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.

Authors:  D S Berman; H Kiat; J D Friedman; F P Wang; K van Train; L Matzer; J Maddahi; G Germano
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

9.  Comparison of same-day protocols using technetium-99m-sestamibi myocardial imaging.

Authors:  J Heo; J Kegel; A S Iskandrian; V Cave; B B Iskandrian
Journal:  J Nucl Med       Date:  1992-02       Impact factor: 10.057

10.  Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-201 for myocardial perfusion imaging.

Authors:  F J Wackers; D S Berman; J Maddahi; D D Watson; G A Beller; H W Strauss; C A Boucher; M Picard; B L Holman; R Fridrich
Journal:  J Nucl Med       Date:  1989-03       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.